APA (7th ed.) Citation

Tu, C., Lin, M., Liu, C., Chen, S., Liu, C., She, M., . . . Su, Y. (2025). Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-29622-x

Chicago Style (17th ed.) Citation

Tu, Chia-Mu, et al. "Intravenous Administration of CpG7909 Lipoplex Enhances Anti-PD1 Immunotherapy by Modulating the Tumor Microenvironment and Inducing Durable Tumor Regression." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-29622-x.

MLA (9th ed.) Citation

Tu, Chia-Mu, et al. "Intravenous Administration of CpG7909 Lipoplex Enhances Anti-PD1 Immunotherapy by Modulating the Tumor Microenvironment and Inducing Durable Tumor Regression." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-29622-x.